NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/21/2023
Back to search
Official data from USPTO
RITALIN LA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
09/21/2023
Trademark type
Word
Nice classes
5
Filing date
10/17/2001
Registration date
11/11/2003
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/21/2023
Last transaction
09/21/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/24/2002
First use in commerce
07/24/2002
Drawing code
1
Owner type
03
Owner location
Basel, CH
Examiner
BALDWIN, SCOTT
Law office
M30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Novartis AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations for the treatment of central nervous system diseases and disorders
Publications
History of USPTO decisions and trademark events.
37 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
09/21/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/21/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/21/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
03/15/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/11/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/10/2013
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/10/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/10/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/10/2013
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
10/08/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
10/08/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/26/2009
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/16/2009
PLGL
ASSIGNED TO PARALEGAL
05/28/2009
E815
TEAS SECTION 8 & 15 RECEIVED
05/21/2009
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/19/2004
PAPER RECEIVED
12/06/2004
R.PR
REGISTERED-PRINCIPAL REGISTER
11/11/2003
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/13/2003
DOCK
ASSIGNED TO EXAMINER
09/12/2003
CFIT
CASE FILE IN TICRS
09/11/2003
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/21/2003
IUAF
USE AMENDMENT FILED
08/08/2003
EISU
TEAS STATEMENT OF USE RECEIVED
08/08/2003
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/09/2003
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
03/18/2003
PUBO
PUBLISHED FOR OPPOSITION
12/24/2002
NPUB
NOTICE OF PUBLICATION
12/04/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/03/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/17/2002
PAPER RECEIVED
07/17/2002
GNFR
FINAL REFUSAL E-MAILED
06/28/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/21/2002
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/21/2002
CNRT
NON-FINAL ACTION MAILED
01/14/2002
DOCK
ASSIGNED TO EXAMINER
01/10/2002
Continuous trademark protection
Get notified about every new filing that threatens RITALIN LA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.